PatentsGlobal
bioAffinity Technologies Secures Hong Kong Patent for CyPath® Lung Cancer Diagnostic, Bolstering Asian Market Entry
bioAffinity Technologies has obtained a Hong Kong patent for its CyPath® Lung diagnostic technology, enhancing its patent portfolio alongside a recent Chinese patent. This dual protection supports the company’s strategy to address the significant lung cancer burden in Asia with its noninvasive, flow cytometry-based di…
Thursday, September 17, 2026